Delivery Order SPE2DR25D3103-SPE2DR26F9Q59
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 mg cephalexin capsules (500-count) under a firm fixed-price contract valued at $1,024.62, with an ultimate completion date of December 2, 2025. This non-set-aside award represents a competitive procurement of pharmaceutical products to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,087.30 to AmerisourceBergen Drug Corp for the supply of Cephalexin 500 mg capsules (500-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a fulfillment under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,609.79 to AmerisourceBergen Drug Corp for 500 mg Cephalexin capsules (500-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance...
- The Defense Logistics Agency awarded a $1,141.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 capsules of Cephalexin 500 mg, a commonly prescribed antibiotic medication. The contract was competitively awarded without set-aside designation and is scheduled for completion by October 24, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,167.36 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for 500 capsules of Cephalexin 250 mg, an oral antibiotic commonly used to treat bacterial infections. This non-set-aside contract is priced on a firm fixed-price basis and has a completion date of December 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cephalexin 500 mg capsules (500-count) on November 17, 2025, with a ceiling value of $1,121.86 and an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is the company's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Cephalexin 500 mg capsules (500-count units) valued at $2,322.83. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires ultimate completion by August 7, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,314,953 units of Cephalexin 500 mg capsules. The contract has a firm fixed price of $4,979.51 and a performance period that runs through August 2, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
- The Defense Logistics Agency awarded a delivery order valued at approximately $643 to Amerisourcebergen Drug Corporation for the supply of 40 capsules of 500mg Cephalexin. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by August 23, 2023. Amerisourcebergen will serve as the prime contractor, with performance taking place under a firm fixed price contract. No major subcontractors or set aside designations were indicated. The Defense...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 500 milligram cephalexin capsules. The $2,051.08 order is part of Amerisourcebergen's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. No set-aside designation was used for this award,...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9Q59Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 mg Cephalexin capsules (500 count) valued at $2,926.11 under a Firm Fixed Price contract. This non-set-aside award was issued on December 17, 2025, with an ultimate completion date of December 18, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, supplying medications, vaccines, medical devices, and other healthcare commodities to military and veteran healthcare systems. Cephalexin is a first-generation cephalosporin antibiotic commonly used across military medical facilities for treating bacterial infections. The company's federal contract portfolio demonstrates extensive experience fulfilling DLA medical supply requirements through competitively awarded delivery orders with consistent firm fixed pricing structures, supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 12/16/25 |